Search Results Page

Surya Roshni in dim light

about 2 years ago

The stock is in the red; from a close of Rs.611.75, opening lower at Rs.590 and fell down 10% to an intraday low at Rs.550.65. Its 52-week close is at Rs.467.15.

Surya Roshni lights up

about 6 years ago

The market is happy with this development and the stock price rose today after two days of consistent fall, rising 5% to Rs.174.50

Surya Roshni lights up

about 6 years ago

The stock opened 4% higher today at Rs.202 and rose over 9.5% to Rs.212, which is just a tad away from its 52-week high of Rs.214.

Surya Roshni hits new high

about 5 years ago

The market seems pretty happy with this news as the stock, which had closed yesterday at Rs.481,75, went on to hit a new high at Rs.514.25.

Surya Roshni lights up

about 5 years ago

Though the stock opened over 1.5% higher at Rs.436 but from there it rose and went up to Rs.504.85, up 14%. Volumes are up over 1.5 times.

Surya Roshni at 20% UC

about 4 years ago

The stock is currently the top gainer on the BSE; from its previous close of Rs.381.15, the stock opened higher at Rs.385.65 and went on to hit the 20% UC

SRF hits a new high

about 12 years ago

SRF is amongst the top gainers on the BSE today. With volumes surging over 7 times, the stock hit a 52-week high at Rs.972 and it is currently up 8% at Rs.950. The stock has shot up after the company announced today that it has acquired Global DuPont Dymel, pharmaceutical propellant business ...

Alembic Pharma falls in the red

about 11 years ago

There is no official report as such which one has seen from the US Govt but there are reports that a legislation has been passed wherein the it has made it mandatory for all active pharmaceutical ingredients (API) to be manufactured locally. This means API exports from India to USA will be banned ...

Sequent Scientific 'warrants' limelight

about 12 years ago

Sequent Scientific hit a new high today at Rs.647 and it continues to trade around the Rs.645 levels, over 15% higher than previous close. Volumes have almost doubled up today at 81,000 shares. Sequent is an integrated pharmaceutical company with a global footprint, operating in the domains ...

Ajanta Pharma zooms to new high

about 12 years ago

Ajanta Pharma engaged in development, manufacture and marketing of pharmaceutical formulations worldwide. In India, it has a presence in the specialty therapeutic segments of Cardiology, Dermatology, Ophthalmology and Pain management. The stock is in the limelight since today morning, hittin ...

CAN INDIA INC PRACTICE YOGA?

about 9 years ago

We all, in our small way have been trying to inculcate the practice of yoga in our day-to-day life; be it breathing right or standing erect or practicing the surya namaskara’s. There is no doubt that with regular concentrated practice, life can change for the good and we will see a change from within and on the outside. And that gave rise to the thought – why can’t India Inc also practice yoga? Why can’t Indian companies incorporate the ashtanga’s of yoga as propounded by Patanjali (the founder of yoga not Baba Ramdev)? This becomes all the more relevant in the backdrop of Indian banks floundering and drowning under the deluge of bad debts.

Novartis has sickly pallor

about 12 years ago

Novartis has a sickly pallor today morning. The stock opened some Rs.4 lower and went on to hit an intra day low at Rs.651.25, down over 4%. It has recovered since then but remains over 2.5% lower. The stock is down on news that the National Pharmaceutical Pricing Authority (NPPA) has impose ...

Sharon Bio-Med in the limelight

about 13 years ago

Sharon Bio-Medical is in the limelight today. This small-cap stock has today seen an over 2.5 times rise in volumes and price is up almost 2% at Rs.42.80. Its intra day high is at Rs.43.15 and 52-week high is at Rs.57.95. The company which manufactures intermediates, active pharmaceutical in ...

INDIAN COMPANIES NEED 'SIRASASANA'!

about 8 years ago

Today, it is international Yoga Day and it is wonderful to see the whole world celebrate this; celebrating yoga like a festival! This is one thing we Indians will be ever be grateful to PM Modi for. We all, in our small way have been trying to inculcate the practice of yoga in our day-to-day life; be it breathing right or standing erect or practicing the surya namaskara’s.

Wanbury turns around

about 10 years ago

Wanbury Limited is India’s fastest growing pharmaceutical company amongst the ‘Top 50 Companies’ as per ORG-IMS, with presence in global Active Pharmaceutical Ingredients (API) market and domestic branded formulations. Its key brands, each falling in the sales range of Rs. 12-28 ...

Camphor Allied perks up

about 11 years ago

Yesterday, the Govt imposed the much awaited and needed anti- dumping duty of US$ 122.14-279.78 per tonne on import of a chemical, used in pharmaceutical and fragrance sectors. This duty is on imports coming from China dn Russia, mainly to protect our domestic industry which has been suffering du ...

BREATHE IN, BREATHE OUT

about 5 years ago

We all, in our small way have been trying to inculcate the practice of yoga in our day-to-day life; be it breathing right or standing erect or practicing the surya namaskara’s. There is no doubt that with regular concentrated practice, life can change for the good and we will see a change from within and on the outside. And that gave rise to the thought – why can’t India Inc also practice yoga?

Alkali Metals

about 18 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Cosmo Films has a good run

about 8 years ago

Cosmo Films is in the limelight today morning. The stock price rose over 8% to Rs.235.25, with volumes jumping up over 7.5 times.

Dr.Reddy’s slinks back into red

about 7 years ago

The stock is the top loser on the BSE since opening bell, going down over 8% to Rs.2352. Its 10% LC for today is at Rs.2302.50.

Granules India tumbles on "observations"

about 10 years ago

Granules India announced on Friday after market closure that Infarmed, the drug regulator of Portugal has given it 11 observations. This is for its facility in Telangana and was issued after Infarmed conducted a renewal inspection on the company's Gagillapur facility. This factory makes pharm ...

Divi’s Labs

about 10 years ago

Divi’s Labs is the top loser on the BSE currently; down almost 19% at Rs.642.25 and this is after hitting a new 52-week low at Rs.635.

Marksans Pharma at a new high

about 10 years ago

Marksans Pharma is the top gainer on the BSE Sensex currently; volumes have jumped on the counter by over 7 times and the stock price, intra day, rose almost 17% at Rs.56.25, getting so close to its 52-week high of Rs.58.30.

Gufic Biosciences inches close to its high

about 9 years ago

Gufic Biosciences rose over 7.5% today to Rs.73.75, so very close to its 52-week high of Rs.77.40. Volumes are robust, going up almost two times.

Dr.Reddy’s Labs among top gainers

about 9 years ago

Dr.Reddy’s Labs is among the top five gainers on the BSE; the stock price soared over 6.5% to Rs.2466.40 and continues to remain firmly in the green

SMS Lifesciences on one-way street

about 9 years ago

SMS Lifesciences got listed on 17th August’17 and since that day, on all the 26 trading sessions it has been breaching the upper circuit, every single day, hitting new highs. It got listed at Rs.135 and today,

Granules India close to a high

about 7 years ago

Granules India today went to Rs.133.05 , so very close to its 52-week high of Rs.135.85. It is now trading at Rs.132 levels.

Lupin says "sayonara"

about 7 years ago

Lupin is in the news today, positive news and the stock price has reacted accordingly. From Monday’s close of Rs.735.95, the stock opened at Rs.749.20 and went to rise over 3% to hit an intraday high at Rs.759.15.

Unichem Labs jumps over 5%

about 7 years ago

Unichem Labs is in the limelight today morning. The stock opened at Rs.171.10, rising over 2.2% and went on to an intraday high at Rs.178.65, a jump of over 5%.

Divi's Labs in serious trouble?

about 9 years ago

There is a very damaging report from Bloomberg which took the effort of accessing the Form 483 and scrutinizing the report. What it has come up with is shocking – it has stated that contrary to the company

Glenmark hits new low

about 7 years ago

Glenmark is the top loser on the BSE since the opening bell. The stock hit a new today at Rs.466.65, going down almost 7%.

Biocon remains in the red

about 9 years ago

Biocon has tanked big time today over 6% to Rs.343.50 the moment it opened for trade but has since then recovered to Rs.357 levels though remains in the red. Its 52-week low

Biocon jumps back into reckoning

about 9 years ago

The stock is today amongst the top five gainers on the BSE; the price rose 6.5% to Rs.419.75, very close to its 52-week high of Rs.424.15.

Natco Pharma in the limelight

about 9 years ago

Natco Pharma is up amongst the top five gainers on the BSE since opening bell. From Friday’s close of Rs.797.65, it went up to Rs.849. Its 52-week high is at Rs.1080.

Granules India rises almost 10%

about 9 years ago

Granules India rose almost 10% today to Rs.106.30 and remains among the top five gainers on the BSE.

Glenmark Pharma spurts over 3.5%

about 8 years ago

Glenmark Pharma rose over 3.5% today to hit an intra day high at Rs.603.35 and continues to remain firmly in the green.

Suven Life jumps over 6%

about 8 years ago

Suven Life Sciences went up over 6.6% to Rs.284.05 and remains firmly in the green. Its 52-week high is at Rs.337.70

Dr.Reddy’s gets going

about 8 years ago

Dr.Reddy’s Labs rose over 4% to Rs.2553 and though it has come off this intra day high, it remains firmly in the green.

Aurobindo Pharma in red

about 7 years ago

Aurobindo Pharma is among the top losers on the BSE currently, going down almost 4% to Rs.588, which is just Rs.20 away from its 52-week low of Rs.566.

Ipca Labs at new high

about 7 years ago

In the market carnage, this is one stock which has hit a 52-week high at Rs.1615.17, a jump of over 17%.

Alembic Pharma is beaming

about 7 years ago

Alembic Pharma is up today after two days of consecutive fall. It opened almost 2.5% higher at Rs.565 and went on hit an intraday high at Rs.568, a rise of almost 3%.

Jubilant Life on the rise

about 7 years ago

The stock, which had closed yesterday at Rs.335.25, opened at Rs.340 and went on to touch the 5% UC at Rs.352

Aurobindo Pharma gets 'suited'

about 7 years ago

The stock opened 4% lower at Rs.427.60 and went down to its intraday low at Rs.425.15 but from there it also shot up briefly

Akums Drugs lists well

about 2 years ago

As against the IPO price of Rs.679, it got listed on the BSE at R.725, went up to Rs.784.65 and is now trading at Rs.762.

HLE Glascoat up 4.5%

about 4 years ago

The stock price rose 4.5% to hit an intraday high at Rs.3600; it down 52% from its 52-week high of Rs.7549, hit in Oct’22. It is not traded much – 2-week average volume is less than 1700 shares

PI Industries in limelight

about 4 years ago

The stock opened 4.5% higher today at Rs.3205.55 and rose further by 11.5% at its intraday high at Rs.3412. Its 52-week high is t Rs.3698.50. Volumes are robust, up almost 10x.

Strides cautiously optimistic

about 4 years ago

The market has reacted positively to this news; from its close of yesterday at Rs.338.35, it opened cautiously optimistic at Rs.340 and rose to an intraday high at Rs.351.55.

Mankind makes strong debut

about 3 years ago

The stock ade a very good debut on the bourses today; as against the IPO price of Rs.1080, the stock got listed at Rs.1300 on the BSE, going up to Rs.1395 and is now trading at Rs.1380 levels.

Lupin hits a new high

about 3 years ago

The stock, which had closed yesterday at Rs.873.80, opened slightly higher at Rs.875.05 and soon went on to hit a new 52-week high at Rs.889.90.

Ajanta Pharma hits new high

about 3 years ago

The stock is very much in the limelight since the morning; the stock which had closed yesterday at Rs.1546, opened higher today at Rs.1625 and rose to a new 52-week high

Marksans close to a high

about 3 years ago

The stock is currently trading at its intraday high point at Rs.117.50, a rise of almost 8% and not too far from its 52-week high of Rs.122.50.

Jubilant Pharmova is jubilant!

about 2 years ago

The stock price is jubilant too! From its close of Rs.1017.30, the stock today opened at Rs.1042.70 and went on to hit a new life-time high today at Rs.1060.15.

Biocon hits a new low

about 4 years ago

The stock which had closed yesterday at Rs.316.20, opened lower at Rs.313 and went down to hit a new 52-week low at Rs.308.25.

IOL Chemicals in news

about 1 year ago

From its close of Rs.65.42, the stock opened higher at Rs.67.90 and rose further to an intraday high at Rs.69.89.

Anlon and Vikran listing tepid

about 1 year ago

Two listings today and both were kind of lacklustre and tepid, reflecting the overall moods of the market.

JB Chem on the rise

about 1 year ago

The open offer has been priced at Rs.1,639.18 per share. Currently, JB Chemicals is trading at Rs.1,736, well above Torrent Pharma’s open offer, signalling confidence in the company’s growth

Nectar hits 2% UC

about 12 months ago

And naturally, the market reacted as best as it could – the moment it opened for trade from its close of Rs.13.31, it hit the 2% UC of the day at Rs.13.57.

Sudeep Pharma lists at premium

about 11 months ago

The stock made a strong debut on the bourses today, with its shares listing at Rs.733.95, a healthy premium over the IPO price of Rs.593, reflecting robust investor appetite

Novartis hits 20% UC

about 8 months ago

The stock was trading at Rs. 996.50, up Rs. 166.05 (20.00% UC) from the previous close of Rs. 830.45 on the BSE. The counter opened at Rs. 904.00 and held firm at the upper band, with VWAP around Rs. 980.08

Pharma stocks in reckoning

about 4 months ago

The rally was broad-based, with Dr. Reddy’s gaining up to 2.6%, Cipla nearly 3%, Laurus Labs over 3%, Zydus Lifesciences around 2.8%, Sun Pharma over 1.5%, while Piramal Pharma surged more than 8% on the supply-opportunity trigger.

Bajaj Health gets 'opium'ed

about 4 years ago

The stock rose over 7% to hit an intraday high today at Rs.365, with volumes jumping up over 2x. Its 52-week high stands at Rs.499.

Lupin in limelight

about 4 years ago

The stock opened weaker at Rs.607, the stock soon rose 1% to an intraday high at Rs.614.60 and is now just about holding on to the green at Rs.611, with volumes up 1.5 times.

Syngene Intnal hits a new high

about 10 years ago

Syngene International hit a new 52-week high today at Rs.510 and despite coming off this high, it remains firmly in the green, up over 5%. This sudden new found love for the stock is on good news that the company’s new R&D facility for Amgen Inc, in Bangalore has finally been commi ...

Hikal at new high

about 6 years ago

The stock, which had closed yesterday at Rs.285.15, opened higher today at Rs.295 and went to hit its 10% UC of the day at Rs.313.65, a new 52-week high

Glenmark Pharma brings hope

about 7 years ago

The stock which had closed yesterday at Rs.329.70, opened higher today at Rs.356.40 and went on to hit an intraday high at Rs.359.

Unichem Labs shines bright

about 7 years ago

It opened over 7% higher at Rs.136.70 and rose to an intraday high at Rs.139.70, which is very close to its 10% UC of the day at Rs.140.15.

Aurobindo Pharma at new high

about 6 years ago

The stock, which had closed yesterday at Rs.750.65, jumped up to hit a new record high today at Rs.791,

Hikal in a haze

about 6 years ago

The stock price today opened with a loss of over 4% at Rs. 113.30 and went down further by more than 5% to hit an intraday low at Rs.112.

Piramal Entp volatile

about 6 years ago

The stock initially reacted positively to this news; opening over 1% higher at Rs.1357 and even rose to an intraday high at Rs.1363 but from there, it has been losing

Lupin rises and falls

about 6 years ago

The stock had closed yesterday at Rs.940.65, surged to Rs.954.35, which was so close to its 52-week high of Rs.955.85. It is now trading at Rs.941 levels

Aarti Drugs at new high

about 6 years ago

The stock price has reacted very positively to this news, opening over 6% higher at Rs.706.35 and rising on to hit a new high at Rs.1025.

Ambalal Sarabhai zooms over 18%

about 6 years ago

today morning opened 18% higher at Rs.33 and went on to hit a new 52-week high at Rs.33.40, with volumes going up over 4 times.

Aether makes great debut

about 4 years ago

As against the IPO price of Rs.642, the stock got listed on the BSE at Rs.706.15, a premium of 10%; it went on to further hit the 10% UC

Bajaj Healthcare hits new high

about 5 years ago

The stock, which had closed yesterday at Rs.636.05, opened a tad lower at Rs.635.65 but soon rose to hit a new high at Rs.675. Volumes are up 6.5 times.

KIMS lists at 22% premium

about 5 years ago

Another new listing today, as against the IPO price of Rs.825, the stock got listed at Rs.1008.90, a premium of over 22%.

Aurobindo Pharma in green

about 5 years ago

The stock opened almost 5% higher at Rs.714, going on to hit an intraday high at Rs.725.90. It has come off the high since then and

Divi’s Labs in the red

about 5 years ago

The stock had hit a new high yesterday at Rs.5313.80 though it ended at Rs.5220.50. Today, it opened higher at Rs.5260 and profit booking

Unichem Labs smart gainer

about 5 years ago

The stock is among the top five gainers on the BSE since morning, opening over 3.5% up at Rs.231.40, rising over 15% to hit an intraday high at Rs.257.

Panacea Biotech at 5% UC

about 5 years ago

The stock which had closed yesterday at Rs.263.80, opened itself today at its 5% UC of the day at Rs.276.95. Its 52-week high is at Rs.453.70.

Natco up over 9%

about 5 years ago

The stock is doing pretty well today morning opened around 4.5% higher at Rs.880 and then surged to an intraday high at Rs.900, up 9%.

Laurus Labs lists at 15% premium

about 10 years ago

Drug maker, Laurus Labs, which had set the IPO price on the upper price band at Rs.428, opened with a huge gap at Rs.490, up almost 15% over IPO price. But it has not been able to sustain at this level and is now down to Rs.475, nevertheless up 11% over IPO price. The issue was subscribed ov ...

Sun Pharma jumps up

about 12 years ago

Sun Pharma is showing some traction in this overall lackluster market. The stock, opened some Rs.10 higher at Rs.956, going up to Rs.960 levels and with profit booking coming at these levels, it has now slipped back to Rs.956, up over 1%. Volumes remain muted. Its 52-weke high is at Rs.1200.70. ...

Sharon Bio hits 20% UC

about 10 years ago

The Board of Sharon Bio-Medicine met yesterday and discussed the current financial position of the Company. Based on that, they have decided to introduce more profitable products to increase capacity utilization. The Board has also decided to get the business to move in the regulated markets spec ...

CHINA's LIKE SALT – NEEDED BUT HARMFUL TOO

about 5 years ago

We can shout and wail till the throat goes hoarse and the eyes pop out. Yet, nothing will change the fact that China today is an irrefutable truth of our lives; we simply cannot live with it and most certainly without it. After the pandemic, the entire world got onto the “ban Chinese goods” bandwagon; so did India in a big way. We all did our bit by not buying Chinese made lanterns and Hindu Gods.

KIMS

about 5 years ago

Verdict :Nothing left on the table for prospective investors
Subscription Start Date :16 Jun 2021 End Date :18 Jun 2021
Issue Size : 2144 crore, Issue Type : Fresh cum OFS
Price Band : Rs.815 to Rs. 825
--------------------------------------------------
Overall Subscription : 3.86x
QIB : 5.26x,HNI :1.89x,Retail :2.9x,Other :1.06x
Listing Date : 28 Jun 2021, , Listing Price : 1009

Fine Organic

about 8 years ago

Verdict :A Fine Pick
Subscription Start Date :20 Jun 2018 End Date :22 Jun 2018
Issue Size : 600 crore, Issue Type : OFS
Price Band : Rs.780 to Rs. 783
--------------------------------------------------
Overall Subscription : 8.99x
QIB : 12.86x,HNI :21.01x,Retail :1.62x
Listing Date : 2 Jul 2018, , Listing Price : 815

AANJANEYA LIFECARE

about 16 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Sudar Inds

about 16 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Claris Lifescience

about 16 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Parabolic Drugs

about 17 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

SYNCOM HEALTHCARE

about 18 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Astec Lifesciences

about 18 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Alkali Metals

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Laurus Labs

about 10 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Greensignal Bio Pharma

about 10 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Dixon

about 9 years ago

Verdict :Topline strong, but margins dicy
Subscription Start Date :06 Sep 2017 End Date :08 Sep 2017
Issue Size : 599 crore, Issue Type : Fresh cum OFS
Price Band : Rs.1760 to Rs. 1766
--------------------------------------------------
Overall Subscription : 117.83x
QIB : 134.66x,HNI :345.61x,Retail :10.6x,
Listing Date : 18 Sep 2017, , Listing Price : 2725

ANU'S LABORATORIES

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

STIMULUS 3.0 – MUCH BETTER AND FOCUSSED

about 6 years ago

The market might not have too many takeaways from this stimulus to really react as such but the fact is that, in the long run, this stimulus of today and the ones announced earlier, along with RBI measures will help India rebuild slowly.

Aether Industries

about 4 years ago

Another ‘Expensive’ IPO
Subscription Start Date :24 May 2022 End Date :26 May 2022
Issue Size : 808 cr, Issue Type : Fresh cum OFS
Price Band : Rs.610 to Rs. 642
--------------------------------------------------
Overall Subscription : 6.26x
QIB : 17.57x,HNI :2.52x,Retail :1.14x,Other :1.06x
Listing Date : 3 Jun 2022, , Listing Price : 704

PRICING OF MEDICINES – HOW MUCH IS TOO MUCH?

about 8 years ago

But it really brings the question back to the fore – how much profit should a drug company make? Given the kind of investment drug companies make in inventing new drugs and patenting, they do deserve a profit. But how much? Is it ethical to squeeze needy patients for as much as it wants?

NO MORE THE ‘PREFERRED’ ONE…

about 8 years ago

Protectionism is at its peak. USA, or rather, Trump feels that the entire world has been having a party at the cost of his country. And he is trying all he can to end this party. He has already fired salvos as China and India has always been on his radar. Starting with H1B, then tariffs on steel, he has made it clear that barriers will only go up further. But raising barriers at a time when the world cannot survive without globalization

NPPA AUTONOMY DILUTED – SICKENING!

about 8 years ago

But for the NPPA, India would have been a free-for-all kind of country where getting basic medicines too would have been a killer. And even in India, like USA, getting cheap medical aid would have been a huge election issue. All this might undergo a change soon.

DECODING THE US FDA JAGONS

about 9 years ago

There was so much hype and hoopla built around the US FDA inspection of Sun Pharma’s Halol plant. This week, it seemed as though the entire pharma sector future hinged on this FDA verdict and today afternoon, the news was finally out. The US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharma’s Halol facility (Gujarat, India) from February 12-23, 2018. At the conclusion of the inspect

WHEN US FDA MEETS INDIAN PHARMA COMPANIES...

about 9 years ago

This is the thought which comes to mind when we read this news today about Biocon also being pulled by the ‘villain’ of Indian pharma companies – the U.S. Food and Drug Administration (U.S. FDA). The stock was down today as its Bengaluru unit has received ten observations on Form 483 by the FDA. This ranges right from nonconformity to procedures and lack of trained and skilled employees

ANOTHER US FDA WARNING - VICTIMS OR INDEED GUILTY?

about 11 years ago

Today, since morning, Dr.Reddy's Labs has been the top loser with the stock losing 15% in intra day trades. And the same ghost has come back to haunt - US FDA. It's almost like, "Say boooo!" and the entire pharma sector stocks shiver and cover in fright. Dr.Reddy's is one of the best run companies of India. In fact it is one of the finest examples of a thorough bred Indian company, which is an example of a best run company is today under the FDA scanner. When companies like these start getting warning letters, you cannot help but wonder if there is indeed

'SUN' TO SHINE OR SHAREHOLDER'S TO TAKE A RUN?

about 13 years ago

In this entire deal, undoubtedly, Daiichi remains the biggest loser. In 2008, the Japanese company bought controlling stake in Ranbaxy for $4.6 billion. The promoter, Malvinder Singh was paid Rs.737/share. Six years on, Daiichi is selling off at $3.2 billion, which is at a loss of over 30%

THE BIG QUESTION - IS RANBAXY A GOOD BUY NOW?

about 13 years ago

This seems like an ongoing saga between Ranbaxy and the US FDA, with one facility after the other coming under the scanner. If one may recollect, it had begun last year when Ranbaxy had pleaded guilty , accepting the felony charges and it has also agreed to pay a criminal fine and forfeiture

Glaxo Pharma Voluntary Open Offer Announced: What Next?

about 13 years ago

GSK Pharma voluntary open offer at Rs. 3,100 per share will see muted response and is likely to remain under subscribed. Taking cues from GSK Consumer's share price performance post closure of its open offer in January this year, retail investors must stay away from the open offer and hold their shares tight.

WYETH's UPCOMING AMALGAMATION WITH PFIZER: Shareholder of which company gains?

about 13 years ago

Swap ratio is likely to be in the range of 1.8:1 to 2.2:1, with former benefiting Wyeth shareholders while latter better for Pfizer shareholders. Company has the carrot (and a real big one) of interim dividend to pacify either of the shareholders.

RANBAXY - TO BUY OR NOT TO BUY?

about 14 years ago

Well, the stock price is up over 3% currently, with more buyers than sellers on the counter. Does this mean that the market does not care about this ruling? It surely does but for the market, more than the felony charges or the loss of reputation, the fact that the company has already provided for the $500 million and this might have any material impact now is what matters. It was happy that the case which

Sensex @ 60,000 Nifty ~18,000

about 5 years ago

Indian Stock Markets: Still Ripe for Investments

PROJECTS WORTH RS.5 LAKH CRORE STALLED!

about 15 years ago

The effect of policy paralysis has made its strong presence felt in the GDP numbers, month after month. They have now become a set of depressing numbers, one which no one, except maybe the Opposition, looks forward to. So if GDP is down and all sectoral growth is down, naturally we are bound to see its effect on the ground too...

INDIA INC AND ITS 'FAMILY' CONNECTIONS

about 10 years ago

Remember the landmark Hindi movie, Trishul? Here, the entire premise of the story is built on the angst of Amitabh Bachchan against his father, Sanjeev Kumar, who betrays his mother, Waheeda Rehman. This is not about Amitabh's anger at being the illegitimate child but more about marriages of convenience. In the movie Sanjeev Kumar

Supriya Lifescience

about 5 years ago

Niche Generic API Exporter
Subscription Start Date :16 Dec 2021 End Date :20 Dec 2021
Issue Size : 700 cr, Issue Type : Fresh cum OFS
Price Band : Rs.265 to Rs. 274
--------------------------------------------------
Overall Subscription : 71.51x
QIB : 31.83x,HNI :161.22x,Retail :56.01x
Listing Date : 28 Dec 2021, , Listing Price : 421

Mankind

about 4 years ago

‘Kind’ for LT, not for ST
Subscription Start Date :25 Apr 2023 End Date :27 Apr 2023
Issue Size : 4,326 cr, Issue Type : OFS
Price Band : Rs.1026 to Rs. 1080
--------------------------------------------------
Overall Subscription : 15.32x
QIB : 49.16x,HNI :3.8x,Retail :0.92x
Listing Date : 9 May 2023, , Listing Price : 1300

Sequent Scientific unit faces suspension

about 10 years ago

Sequent Scientific is down in the red in today’s trade. Intra day, the stock declined almost 6.5% to Rs.135; it has recovered from there and is now at R.140 levels, down 3%. Its 52-week low is at Rs.124.30 and high at Rs.260. Not the US FDA but the Maharashtra Food and drug Administrat ...

Ranbaxy slumps deep into red

about 13 years ago

Ranbaxy Labs is currently the top loser on the BSE, down over 15% at Rs.353.30, with volumes spiking up almost 3 times. The stock went as low as Rs.335 or almost 20% in the early morning trades. The stock is down on news coming in that US FDA has banned imports to USA from Ranbaxy due to man ...

Pharma companies sulk as prices go down

about 11 years ago

Abbott Healthcare, Lupin, Alembic, Alkem Labs, Novartis and many more such pharma companies are trading in the red. Cipla and Sun are just about holding onto the green. It is always seen, what is good for the peopleis not good for the market. If prices are reduced, the markets sulk while peo ...

Shilpi Medicare up and about

about 11 years ago

Shilpi Medicare announced yesterday after market hours that two of its API sites in Karnataka have received GMP compliance certificate from Japan’s health regulator, PMDA. Good manufacturing practice (GMP) is a system for ensuring that products are consistently produced and controlled ...

WHO pushes up Anuh Pharma

about 11 years ago

Lesser known Anuh Pharma, with a market cap of over Rs.800 crore, is in the limelight today. The stock rose some 2.5% higher, to spurt up to an intra day high of Rs.339, up almost 9%. It currently remains around 6% up at Rs.330 levels. The company announced yesterday after market hours that ...

Astec Life jumps on open offer

about 11 years ago

Astec Lifesciences is pretty much in the limelight today morning. Opening Rs.10 higher at Rs.250, the stock went on to Rs.262.90 and is now back to Rs.248, still up in the green; some 3% higher. Volumes were up over two times. The stock is up on the open offer coming from the company, which i ...

Kopran: Volumes surge on sale of division

about 11 years ago

Parijat Group’s Kopran Limited’s board of directors have approved the sale of consumer care division with effect from 1st April 2015, along with all its assets and liabilities. However, name of buyer, sale consideration and other details of the transaction are still awaited ...

Suven gets a shot in the arm

about 11 years ago

Suven Life Sciences is up 5.9% at Rs. 248.85 on NSE this morning, with total traded volume of over 11 lakh shares, as against 2 week average daily traded quantity of less than 5 lakh shares on NSE. Even on BSE, volumes of 2.6 lakh shares are more than double the average volumes of 1.2 lakh shares ...

Sharon Bio behaves contrary

about 11 years ago

Sharon Bio-Medicine is showing a complete contrary behavior to the news, which should have actually put the stock in the red. The news is that the US Food and Drug Administration (FDA) has issued a warning letter to Sharon Bio-medicine for failure to pay generic drug user fee by its owner for thr ...

GMM Pfaudler hits a new high

about 12 years ago

GMM Pfaudler has shown some 3.5 times surge in volumes and went on to hit a new high at Rs.282.05. It has come down from the level and is now at Rs.268.90, which is 4.5% higher than yesterday’s close. The company’s promoter, Pfaudler, yesterday late evening, made an open offer to ...

Strides Arcolab zooms up

about 12 years ago

Strides Arcolab is in the limelight today, currently up over 4% at Rs.730.80 and this is after hitting an intra day high at Rs.748.35. The company, in a surprise move, announce merger within itself of Shasun Pharma in an all-stock deal. As per the deal, Shasun shareholders will ge ...

IPCA Labs spooked by US FDA

about 12 years ago

IPCA Labs is currently the top loser on the BSE, down 9% at Rs.763.60, with an intra day low at Rs.752 and this was though the stock had opened at Rs.832. The stock reacted sharply to the announcement made by the company in the early trading hours that it had voluntarily stopped shipments fr ...

Wipro in the green

about 13 years ago

After the weak few days due to the stronger rupee, Wipro is up in the green today. The stock, which had closed yesterday at Rs.481.50, opened higher at Rs.486, going on to hit an intra day high at Rs.496.40. It currently remains at Rs.493 levels, up almost 2.5%. The stock is up after the com ...

Torrent Pharma looks healthy

about 13 years ago

Torrent Pharma has hit a new high today at Rs.607.70, zooming up in the early morning trade by over 9%. It has since then come off the highs and is currently at Rs.575. Volumes are up 4 times. The stock hit a high, celebrating the news that the CCI has approved the company’s proposed R ...

Arrow Coated hits upper circuit, again

about 13 years ago

Arrow Coated Products has once again breached the upper circuit today also at Rs.44.10, up 5%. Yesterday too, the stock was frozen at the 5% upper filter at Rs.42. This sudden spike up in the stock, that too strong enough to consistently hit the upper circuit is on the back of the company&rs ...

Torrent Pharma looks healthy

about 13 years ago

Torrent Pharma is doing very well today morning, hitting a new 52-week high at Rs.538.40, with an almost 2 times surge in volumes. It has come off the highs but remains almost 9% up at Rs.517 levels. The stock is up after the company yesterday declared its Q3FY14 numbers after market closure ...

Blue Jet

about 3 years ago

Niche and Growing Business
Subscription Start Date :25 Oct 2023 End Date :27 Oct 2023
Issue Size : Rs. 840 crore, Issue Type : OFS
Price Band : Rs.329 to Rs. 346
--------------------------------------------------
Overall Subscription : 7.94x
QIB : 13.72x,HNI :13.59x,Retail :2.22x
Listing Date : 1 Nov 2023, , Listing Price : 380

Aurobindo in great health

about 13 years ago

Aurobindo Pharma is a stock in the limelight today morning. The stock has spurted up over 4.5% at Rs.403.35, closer to its intra day high at Rs.404.20. Its 52-week high to not too far off at Rs.417.90. The stock is reacting today to the news its announced on Friday, that its European subsidi ...

IPCA Labs on the buzz

about 13 years ago

IPCA Labs last month had hit a new 52-week high at Rs.744.35 and today the stock is once again showing activity. The stock had closed yesterday at Rs.686 and it opened today at Rs.689.90 and went on to hit an intra day high at Rs.696. The stock is buzzing on news which it announced yesterday ...

Wanbury continues to do well

about 13 years ago

Wanbury continues on its strong ride into the green. The stock was locked on the 20% upper circuit on Friday at Rs.22.65 and today, it has once again opened stronger. It is currently up almost 4.5% at Rs.23.65, after having hit an intra day high at Rs.25.90. Volumes have risen over 5 times. ...

Aditya Birla Capital in the limelight

about 7 years ago

Post this development, Aditya Birla Capital, the stock price has been rising for the last 2 days, gaining 5% during this period. The stock touched an intraday high at Rs.92.55, rising almost 2.5%.

PNB back in reckoning

about 8 years ago

Scam hit PNB is in the green today, going up over 4% to Rs.94.20 and the mood on the counter currently looks positive.

Idea Cellular rings a good tune

about 9 years ago

Idea Cellular is the top gainer on the BSE currently. It rose 13% to Rs.118, tantalizingly close to its 52-week high at Rs.123.75.

Punj Lloyd spurts up into the green

about 10 years ago

Yesterday, after market hours, Punj Lloyd announced that Punj Lloyd Infrastructure Limited (“PLIL”), a wholly owned subsidiary of the Company has executed definitive agreements with India Power Green Utility. This to co-develop 30 MW of solar assets in Uttarakhand. Each of these ...

Symbiotec Pharmalab

about 2 months ago

High Growth Prospects
Subscription Start Date :24 Aug 2026 End Date :27 Aug 2026
Issue Size : Rs. 1,757 cr, Issue Type : Fresh cum OFS
Price Band : Rs.938 to Rs. 988
--------------------------------------------------
Overall Subscription : 71.26x
QIB : 172x,HNI :74x,Retail :13x,Other :15.4x
Listing Date : 1 Sep 2026, , Listing Price : 988

Corona Remedies

about 10 months ago

All for Growth
Subscription Start Date :8 Dec 2025 End Date :10 Dec 2025
Issue Size : Rs. 655 cr, Issue Type : OFS
Price Band : Rs.1008 to Rs. 1062
--------------------------------------------------
Overall Subscription : 137x
QIB : 208.9x,HNI :278.5x,Retail :28.7x
Listing Date : 15 Dec 2025, , Listing Price : 1470

Rubicon Research

about 1 year ago

Shines like a Ruby!
Subscription Start Date :9 Oct 2025 End Date :13 Oct 2025
Issue Size : Rs. 1377 cr, Issue Type : Fresh cum OFS
Price Band : Rs.461 to Rs. 485
--------------------------------------------------
Overall Subscription : 103.9x
QIB : 130.26x,HNI :97.61x,Retail :35.47x,Other :16.8x
Listing Date : 16 Oct 2025, , Listing Price : 620

Anlon Health

about 1 year ago

Debtors overshadow Margins
Subscription Start Date :26 Aug 2025 End Date :29 Aug 2025
Issue Size : Rs. 121 cr, Issue Type : Fresh Issue
Price Band : Rs.86 to Rs. 91
--------------------------------------------------
Overall Subscription : 7.12x
QIB : 1.07x,HNI :10.61x,Retail :47.29x
Listing Date : 3 Sep 2025, , Listing Price : 91

Senores Pharma

about 2 years ago

On a Growth Path
Subscription Start Date :20 Dec 2024 End Date :24 Dec 2024
Issue Size : Rs. 582 cr, Issue Type : Fresh cum OFS
Price Band : Rs.372 to Rs. 391
--------------------------------------------------
Overall Subscription : 93.41x
QIB : 94.66x,HNI :96.11x,Retail :89.23x,Other :19.92x
Listing Date : 30 Dec 2024, , Listing Price : 600

Akums Drugs

about 2 years ago

Aggressively Priced
Subscription Start Date :30 Jul 2024 End Date :1 Aug 2024
Issue Size : Rs. 1,857 cr, Issue Type : Fresh cum OFS
Price Band : Rs.646 to Rs. 679
--------------------------------------------------
Overall Subscription : 63.44x
QIB : 90.09x,HNI :42.1x,Retail :20.8x,Other :4.14x
Listing Date : 6 Aug 2024, , Listing Price : 725

Innova Captab

about 3 years ago

Pricey for the Average Financials
Subscription Start Date :21 Dec 2023 End Date :26 Dec 2023
Issue Size : Rs. 570 cr, Issue Type : Fresh cum OFS
Price Band : Rs.426 to Rs. 448
--------------------------------------------------
Overall Subscription : 55.26x
QIB : 116.7x,HNI :65x,Retail :17.15x
Listing Date : 29 Dec 2023, , Listing Price : 452

Dr Reddy's top loser

about 3 months ago

The stock is currently the top loser on the BSE, falling over 5% to Rs. 1,272.90 after the company flagged manufacturing issues in certain batches of its Semaglutide product. The stock slipped from its previous close of Rs. 1,348.70 and touched an intraday low of Rs. 1,261.20